Price and Variability in Hospital Charges for Generic Indomethacin Suppositories

Noah M Feder; Inmaculada Hernandez; William B Feldman; Mathavan Murali; Aaron S Kesselheim; B Joseph Elmunzer; Walid F Gellad

doi:10.1001/jamanetworkopen.2024.35528

Price and Variability in Hospital Charges for Generic Indomethacin Suppositories

JAMA Netw Open. 2024 Sep 3;7(9):e2435528. doi: 10.1001/jamanetworkopen.2024.35528.

Authors

Noah M Feder¹, Inmaculada Hernandez², William B Feldman^{3

4}, Mathavan Murali¹, Aaron S Kesselheim³, B Joseph Elmunzer⁵, Walid F Gellad¹

Affiliations

¹ Center for Pharmaceutical Policy and Prescribing, University of Pittsburgh, Pittsburgh, Pennsylvania.
² UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California.
³ Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
⁴ Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
⁵ Division of Gastroenterology and Hepatology, Medical University of South Carolina, Charleston.

No abstract available

Plain language summary

This cross-sectional study examines how list prices for indomethacin have changed since 2019 and characterizes variation in hospital charges for the drug, including gross charges and discounted cash prices.

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
Anti-Inflammatory Agents, Non-Steroidal / economics
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Drugs, Generic* / economics
Hospital Charges* / statistics & numerical data
Humans
Indomethacin* / administration & dosage
Indomethacin* / economics
Indomethacin* / therapeutic use
Suppositories
United States

Substances

Indomethacin
Suppositories
Drugs, Generic
Anti-Inflammatory Agents, Non-Steroidal